Table 2 Radiobiological parameters used in the LKB model for the calculation of NTCP.

From: Retrospective evaluation of high-dose-rate brachytherapy multicriteria planning using physical dose versus radiobiological criteria for prostate cancer

Side effect

Urethra stricture

Rectum proctitis, necrosis stenosis and fistula

Bladder contracture and severe volume loss

m

0.23 \(^{b}\)

0.15\(^{a}\)

0.11\(^{a}\)

D50 (Gy)

116.7 \(^{b}\)

80\(^{a}\)

80\(^{a}\)

n

0.3 \(^{b}\)

0.12 \(^{a}\)

0.5 \(^{a}\)

\(\alpha /\beta\) (Gy)

5 \(^{b}\)

5.4 \(^{c}\)

7.5 \(^{c}\)

  1. \(^{a}\)11 \(^{b}\)30 \(^{c}\)31